Ignite Creation Date:
2024-05-06 @ 8:11 AM
Last Modification Date:
2024-10-26 @ 11:57 AM
Study NCT ID:
NCT02689362
Status:
COMPLETED
Last Update Posted:
2018-08-14
First Post:
2016-02-10
Brief Title:
Evogliptin in Type 2 Diabetes Mellitus EVOLUTION EVOgLiptina no Diabetes Mellitus TIpO 2
Sponsor:
Eurofarma Laboratorios SA
Organization:
Eurofarma Laboratorios SA
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-08-08
Start Date Type:
ACTUAL
Primary Completion Date:
2018-08-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-08-09
Completion Date Type:
ACTUAL
First Submit Date:
2016-02-10
First Submit QC Date:
February 18 2016
Study First Post Date:
2016-02-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-12
Last Update Post Date:
2018-08-14
Last Update Post Date Type:
ACTUAL